Friedrich Graf Finckenstein
2019
In 2019, Friedrich Graf Finckenstein earned a total compensation of $3.4M as Chief Medical Officer at Lion Biotechnologies.
Compensation breakdown
Bonus | $160,000 |
---|---|
Non-Equity Incentive Plan | $82,500 |
Option Awards | $2,655,440 |
Salary | $450,000 |
Other | $11,200 |
Total | $3,359,140 |
Finckenstein received $2.7M in option awards, accounting for 79% of the total pay in 2019.
Finckenstein also received $160K in bonus, $82.5K in non-equity incentive plan, $450K in salary and $11.2K in other compensation.
Rankings
In 2019, Friedrich Graf Finckenstein's compensation ranked 3,645th out of 13,971 executives tracked by ExecPay. In other words, Finckenstein earned more than 73.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,645 out of 13,971 | 74th |
Division Manufacturing | 1,317 out of 5,701 | 77th |
Major group Chemicals And Allied Products | 457 out of 2,200 | 79th |
Industry group Drugs | 383 out of 1,886 | 80th |
Industry Biological Products, Except Diagnostic Substances | 85 out of 389 | 78th |
Source: SEC filing on April 27, 2021.
Finckenstein's colleagues
We found three more compensation records of executives who worked with Friedrich Graf Finckenstein at Lion Biotechnologies in 2019.